HPLC method for amino acids profile in biological fluids and inborn metabolic disorders of aminoacidopathies

被引：46

作者：

Babu S.V.S. ^{[1
]}

Shareef M.M. ^{[1
]}

Shetty A.P.K. ^{[1
]}

Shetty K.T. ^{[1
]}

机构：

[1] Clinical Biochemistry Unit, Department of Neurochemistry, National Institute of Mental Health and Neurosciences

来源：

Indian Journal of Clinical Biochemistry | 2002年 / 17卷 / 2期

关键词：

Amino acidopathies; Amino acids profile; Inborn metabolic disorders; O-; pthalaldehyde; Reverse phase HPLC;

D O I：

10.1007/BF02867967

中图分类号：

学科分类号：

摘要：

Quantification of total and individual amino acids in biological fluids such as plasma, urine and cerebrospinal fluid has an important diagnostic implication in laboratory medicine. The present paper describes protocols for the assay of total amino acids by modified method based on dinitrophenyl and HPLC profile involving pre-column derivatization with o-pthalaldehyde (OPA) derivatization, respectively. The method, based on the alkylation of -SH groups prior to OPA derivatization of amino acids followed by reverse phase high performance liquid chromatography, provide a comprehensive profile of more than twenty amino acids (including -SH group containing) in a single run lasting about 45 minutes. The present study, apart from establishing the normal profile of amino acids in plasma of Indian sub population, also presents HPLC profile for some of the rare amino acidopathies.

引用

页码：7 / 26

页数：19

共 15 条

[1]

Deyl Z., Hyanek J., Horakova M., Profiling of amino acids in body fluids and tissues by means of liquid chromatography, J. Chromatogr, 379, pp. 177-250, (1986)

[2]

Jacobsen D.W., Homocysteine and vitamins in cardiovascular disease, Clin. Chem, 44, pp. 1833-1843, (1998)

[3]

Hankey G.J., Eikelboom J.W., Homocysteine and vascular disease, The Lancet, 354, pp. 407-413, (1999)

[4]

Welch G.N., Loscalzo J., Homocysteine and atherothrombosis, New Engl. J. Med, 338, pp. 1042-1050, (1998)

[5]

Boushey C.J., Beresford S.A.A., Omen G.S., Motulsky A.G., A quantitative assessment of plasma homocysteine as a risk factor in vascular disease, JAMA, 274, pp. 1049-1057, (1995)

[6]

Frantzen F., Faaren A.L., Alfheim I., Nordhei A.K., Enzyme conversion immuno assay for determining total homocysteine in plasma or serum, Clin. Chem, 44, pp. 311-316, (1998)

[7]

Refsum H., Ueland P.M., Svardal A.M., Fully automated fluorescence assay for determining total homocysteine in plasma, Clin. Chem, 35, pp. 1921-1927, (1989)

[8]

Robenstein D.L., Yamaahita G.T., Determination of homocysteine, penicillamine and their symmetrical and mixed disulfides by liquid chromatography with electrochemical detection, Anal. Biochem, 80, pp. 259-263, (1989)

[9]

Thomson S.B., Tucker D.J., Determination of homocysteine in urine, J. Chromatogr, 338, pp. 201-208, (1985)

[10]

Mansoor M.A., Svardal A.M., Ueland P.M., Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma, Anal. Biochem, 200, pp. 218-229, (1992)

← 1 2 →